These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 19293472)

  • 21. Comparative evaluation of target-specific GFP gene silencing efficiencies for antisense ODN, synthetic siRNA, and siRNA plasmid complexed with PEI-PEG-FOL conjugate.
    Kim SH; Mok H; Jeong JH; Kim SW; Park TG
    Bioconjug Chem; 2006; 17(1):241-4. PubMed ID: 16417275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formulation and delivery of siRNA by oleic acid and stearic acid modified polyethylenimine.
    Alshamsan A; Haddadi A; Incani V; Samuel J; Lavasanifar A; Uludağ H
    Mol Pharm; 2009; 6(1):121-33. PubMed ID: 19053537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulating multidrug resistance gene in leukaemia cells by short interfering RNA.
    Lim MN; Lau NS; Chang KM; Leong CF; Zakaria Z
    Singapore Med J; 2007 Oct; 48(10):932-8. PubMed ID: 17909680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivery of small interfering RNA to mammalian cells in culture by using cationic lipid/polymer-based transfection reagents.
    Brazas RM; Hagstrom JE
    Methods Enzymol; 2005; 392():112-24. PubMed ID: 15644178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo.
    Chien PY; Wang J; Carbonaro D; Lei S; Miller B; Sheikh S; Ali SM; Ahmad MU; Ahmad I
    Cancer Gene Ther; 2005 Mar; 12(3):321-8. PubMed ID: 15578064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a novel nonviral gene silencing system that is effective both in vitro and in vivo by using a star-shaped block copolymer (star vector).
    Mori T; Ishikawa A; Nemoto Y; Kambe N; Sakamoto M; Nakayama Y
    Bioconjug Chem; 2009 Jun; 20(6):1262-9. PubMed ID: 19456093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel anionic dendrimer for improved cellular delivery of antisense oligonucleotides.
    Hussain M; Shchepinov M; Sohail M; Benter IF; Hollins AJ; Southern EM; Akhtar S
    J Control Release; 2004 Sep; 99(1):139-55. PubMed ID: 15342187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A unique and highly efficient non-viral DNA/siRNA delivery system based on PEI-bisepoxide nanoparticles.
    Swami A; Kurupati RK; Pathak A; Singh Y; Kumar P; Gupta KC
    Biochem Biophys Res Commun; 2007 Nov; 362(4):835-41. PubMed ID: 17822674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels.
    Hassani Z; Lemkine GF; Erbacher P; Palmier K; Alfama G; Giovannangeli C; Behr JP; Demeneix BA
    J Gene Med; 2005 Feb; 7(2):198-207. PubMed ID: 15515135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A peptidomimetic siRNA transfection reagent for highly effective gene silencing.
    Utku Y; Dehan E; Ouerfelli O; Piano F; Zuckermann RN; Pagano M; Kirshenbaum K
    Mol Biosyst; 2006 Jun; 2(6-7):312-7. PubMed ID: 16880950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.
    Kunze D; Wuttig D; Kausch I; Blietz C; Blumhoff L; Burmeister Y; Kraemer K; Fuessel S; Toma M; Schwenzer B; Meye A; Grimm MO; Hakenberg OW; Jocham D; Wirth MP
    Int J Oncol; 2008 May; 32(5):1049-56. PubMed ID: 18425331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications.
    Dalby B; Cates S; Harris A; Ohki EC; Tilkins ML; Price PJ; Ciccarone VC
    Methods; 2004 Jun; 33(2):95-103. PubMed ID: 15121163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
    Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
    Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene profiling study of G3139- and Bcl-2-targeting siRNAs identifies a unique G3139 molecular signature.
    Anderson EM; Miller P; Ilsley D; Marshall W; Khvorova A; Stein CA; Benimetskaya L
    Cancer Gene Ther; 2006 Apr; 13(4):406-14. PubMed ID: 16195754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing invariant chain of DCs enhances Th1 response using small interfering RNA.
    Ke S; Chen XH; Li H; Li JF; Gu QL; Liu BY; Zhu ZG
    Cell Biol Int; 2007 Jul; 31(7):663-71. PubMed ID: 17296316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 17β-estradiol induces CD40 expression in dendritic cells via MAPK signaling pathways in a minichromosome maintenance protein 6-dependent manner.
    Xie H; Hua C; Sun L; Zhao X; Fan H; Dou H; Sun L; Hou Y
    Arthritis Rheum; 2011 Aug; 63(8):2425-35. PubMed ID: 21538324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Silencing of caspase-8 and caspase-3 by RNA interference prevents vascular endothelial cell injury in mice with endotoxic shock.
    Matsuda N; Takano Y; Kageyama S; Hatakeyama N; Shakunaga K; Kitajima I; Yamazaki M; Hattori Y
    Cardiovasc Res; 2007 Oct; 76(1):132-40. PubMed ID: 17601517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of in vivo gene delivery methods for antisense therapy in ligament healing.
    Nakamura N; Timmermann SA; Hart DA; Kaneda Y; Shrive NG; Shino K; Ochi T; Frank CB
    Gene Ther; 1998 Nov; 5(11):1455-61. PubMed ID: 9930298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific inhibition of human telomerase activity by transfection reagent, FuGENE6-antisense phosphorothioate oligonucleotide complex in HeLa cells.
    Tao M; Miyano-Kurosaki N; Takai K; Takaku H
    FEBS Lett; 1999 Jul; 454(3):312-6. PubMed ID: 10431829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.